The WHO injection safety assessment tool: first results SIGN Meeting 2001 New Delhi, India.

Slides:



Advertisements
Similar presentations
From Assessment to Planning Injection Safety Assessments coordinated by WHO/Vaccines and Biologicals in the Eastern Mediterranean Region Carsten Mantel,
Advertisements

WHO Regional Office for Europe Vaccine preventable diseases and Immunization programme Diphtheria Incidence in the WHO European Region 1990 Source; WHO/UNICEF.
1 |1 | Countries using and planning to introduce IPV July 2014 status report This slide deck provides a summary per country on the status of planning for.
Managing Sharps Waste In Cambodia SIGN Meeting, 25 October 2002 Cambodiana Hotel, Phnom Penh Dr. Chea Kim Ly, Deputy Director National Immunization Program.
Injection Safety in EPI: More than just AD Syringes and Safety Boxes World Health Organization HTP/V&B/EPI.
1 |1 | Countries using and planning to introduce IPV.
Vaccine in National Immunization Programme Update March 2015.
1 |1 | Countries using and planning to introduce IPV.
1 |1 | Countries using and planning to introduce IPV.
World Health Organization
TITLE from VIEW and SLIDE MASTER | August 7, |1 | Countries with Hib vaccine in the national immunization programme; and planned introductions *
WHO Regional Office for Europe Vaccine preventable diseases and Immunization programme Measles containing vaccine (MCV1) coverage in the WHO European Region.
Evidence and Information for Policy The World Health Survey Health System Metrics Glion, September 2006.
World Health Organization
Reaching the 2010 Measles Mortality Reduction Goal-can SEARO get there? Meeting of the Partners for Measles Advocacy Washington DC, September 2008.
Polio Update Pre Tender Meeting 11 th December 2008 UNICEF Supply Division.
1 |1 | Countries using and planning to introduce IPV.
Highlights of New WPV Cases 34 new cases in 5 countries 14 cases (14 W3) but no new district in India Most recent date of onset 03 Oct 1 case (W1) but.
Data in WHO HQ as of 09 October 2012 Highlights of New Wild Poliovirus Cases The boundaries and names shown and the designations used in the maps in this.
Evidence and Information for Policy Christopher J.L. Murray Executive Director Evidence and Information for Policy World Health Organization National Capacity.
1 |1 | Countries using and planning to introduce IPV.
Increasing Access to Injection Equipment in Burkina Faso: When Essential Drugs Programmes Improve Injection Safety Sophie Logez Phamaciens Sans Frontières.
1 |1 | Countries using and planning to introduce IPV and the global status of bOPV registration Countries using and planning to introduce IPV and the global.
Data in WHO HQ as of 17 Apr 2012 Highlights of New Wild Poliovirus Cases The boundaries and names shown and the designations used in the maps in this document.
Improvement of Injection Safety in Burkina Faso, JF. Aguilera, J. Fitzner, A. Yaméogo, Y. Hutin.
A media campaign to promote safe immunization injections in Tanzania (This presentation was modified from its original layout. It has been adapted for.
Measles Mortality Reduction: the risk of resurgence Global Immunization Meeting Geneva, Switzerland 1-3 February 2010 Balcha Masresha, WHO/AFRO.
Documenting (Driving) Progress in Immunization Injection Safety Philippe Duclos, WHO Presented at the SIGN annual meeting, Cairo, Egypt, Oct th,
Sustaining the gains and reaching milestones on the way towards elimination of measles and rubella 15 September 2015 Dr Peter Strebel, WHO, IVB/EPI.
Abstract Problem Statement: As in many former socialist economies, anecdotal reports suggested that injections were overused to administer medications.
Global Programme on Evidence for Health Policy The use of GIS in the Global Programme on Evidence for Health Policy (GPE) Meeting on Cartography and Geographic.
Vaccine in National Immunization Programme Update April 2016.
World Health Organization
SAGE 2010 Sampling Distribution
Logez S, Hutin Y, Somda P, Thualt J, Holloway K
reporting rate of discarded cases* per 100'000 population**
Alarcos Cieza, MSc, MPH, PhD Coordinator Disability and Rehabilitation
World Health Organization
Monthly Distribution of Wild Poliovirus Cases1,
SAGE 2009 Sampling Distribution
06/12/2018 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1Environmental sampling, contacts of AFP cases, community.
Countries Having Introduced Hib Vaccine
Countries Having Introduced Hib Vaccine and Infant Hib Coverage, 2010
Sampling Distribution
15/01/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week The boundaries and names shown and the designations used in.
Non-polio AFP Rate July 2014 – June 2015 July 2015 – June 2016
Monthly Distribution of Wild Poliovirus Cases1,
(70 countries or 36%) (23 countries or 12%)
Countries with Genotype data available
Countries Using Hib Vaccine in National Immunization Schedule in 2010 and Countries Approved for GAVI Support for Use from 2011 Onwards Yes (166 countries.
World Health Organization
24/02/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1Environmental sampling, contacts of AFP cases, community.
World Health Organization
Onset of most recent WPV1 Case Number of WPV infected districts
08/04/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1Environmental sampling, contacts of AFP cases, community.
Countries having introduced HepB vaccine
No new positives this week
05/04/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1Environmental sampling, contacts of AFP cases, community.
08/04/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week The boundaries and names shown and the designations used in.
Mapping Levels of Palliative Care Development: A Global Update
Countries Using Mening Vaccine in National Immunization Schedule 2011
- Use same categories as for bar chart below Introduced Without GAVI
Onset of most recent case Number of infected districts
04/05/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1contacts of positive AFP cases, community, healthy children.
Meningitis/Encephalitis Surveillance Countries reporting to WHO Network or with Other (non-WHO Network) Surveillance Activities WHO Network (46 member.
16/05/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1Environmental sampling, contacts of AFP cases, community.
27/08/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1Environmental sampling, contacts of AFP cases, community.
2,100 4,200 1,050 Kilometers < 90% (75 countries or 39%)
World Health Organization
World Health Organization
Presentation transcript:

The WHO injection safety assessment tool: first results SIGN Meeting 2001 New Delhi, India

Rationale for Assessments zAssessments identify local problems to design effective, efficient interventions zData provide baseline information, & suggest indicators for monitoring zData open the door to dialogue èOverall, it shall help countries designing and implementing a safe injection policy

Standard assessment of injection practices Objectives z To determine if the country meets necessary requirements for staff competence, equipment, supplies, and waste disposal z To assess if the injections are administered according to recommended best practices z To estimate the proportion of healthcare facilities where injection practices are safe

Methods zStandardized and representative method to allow for: yMeasuring and documenting progress yComparison across countries zSimple/structured and flexible y2-3 weeks zCan be adjusted to country needs (for instance focus on immunization and/or therapeutic injections) Standard assessment of injection practices

Methods (contd.) zCross sectional observational study yObservation of supplies yObservation of injections yInterview of healthcare workers zTwo stage cluster sampling y8 districts selected y10 health care centres in each district èRepresentative of the country Standard assessment of injection practices

The designation employed and the presentation of material on this map do not imply the expression of any opinion whatsoever on the part of the secretariat of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. Safe injection assessments June 2000-August 2001 Nepal, Kyrgyzstan, Egypt, Morocco, Oman, Syria, Paraguay, Honduras, Burkina Faso, Niger, Ethiopia, Chad, Zimbabwe and Gambia

First results: use of injection material (based 9 available reports) z3 countries are not using sterilizable injection material any more zIn 6 countries, between 6 and 84% of observed injections are done with sterilizable material (countries in transition) z1 country is using AD-syringes for all observed immunizations zOnly 2 countries practice the bundling of vaccines, injection equipment and safety boxes for the immunization activities

Risk for the recipient (Use of sterile equipment for injections) y100% use of sterile equipment for all observed injections in only one country (using disposable equipment) yIn 6 countries using sterilizable equipment: xNon documented sterilisation regularly with TST spot xUse of sterile equipment between 55 and 88% xSpare parts and a 2 day supply were not available in a majority of the health facilities yCountries using AD or disposable syringes have between 85 to 100% of health facilities using sterile equipment

Risk for the health care worker zUse of safety-boxes observed in 60% of health facilities (0-89%) zSharps found in open containers in 80% of health facilities (34-95%) zUsed syringes recapped in 54% of health facilities (16-71%) zAt least 1 needle-stick injury in the last 12 months for 61% of health care workers (22- 76%)

Risk for the community zNo sharps found in the surroundings of health facility in 50% of cases (27-77%) zWaste disposal, open burning or dumping unsupervised in 39% of health facilities (18-64%) zHealth care waste policy in only 5% of the health facilities (0-9%)

Conclusions zThe risks for the recipient are high in countries using sterilizable equipment zThe safety of the health care worker and the community is a problem in all observed countries zLimitations in comparing across countries - the tool is designed to help individual countries to develop and implement a safe injection policy zNext step: very important to follow-up these assessments, country by country...